Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-carnitine CoA-transferase is a bacterial enzyme, notably present in *Escherichia coli* and other gammaproteobacteria, that catalyzes the reversible transfer of a CoA group from gamma-butyrobetainyl-CoA or crotonobetainyl-CoA to L-carnitine, resulting in the formation of L-carnitinyl-CoA and gamma-butyrobetaine[2][4][5][7][8][9]. This enzyme (also called CaiB) is encoded by the cai operon, and is important in microbial carnitine and fatty acid metabolism. The enzyme belongs to the family III CoA-transferases and plays a central role in utilizing L-carnitine by enabling bacteria to produce energy from carnitine substrates under certain conditions[5][8]. The CaiB enzyme has been structurally characterized (dimer of subunits, with a Rossmann fold domain)[7]; its catalytic mechanism involves a covalent intermediate with an aspartate residue, allowing transfer of the CoA group between substrates[5][7]. Important note: L-carnitine CoA-transferase (CaiB) should not be confused with carnitine acetyltransferase (CRAT) or mitochondrial carnitine palmitoyltransferase enzymes, which are important in human fatty acid metabolism and disease. L-carnitine CoA-transferase is primarily characterized in bacteria and does not have a direct therapeutic or disease role in humans[2][4][5][7][8].
Catalyzes reversible transfer of CoA from gamma-butyrobetainyl-CoA (or crotonobetainyl-CoA) to L-carnitine, generating L-carnitinyl-CoA and gamma-butyrobetaine
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-carnitine CoA-transferase (CaiB).